Bríd O’Flaherty
Bríd O’Flaherty is a barrister appointed as the chairwoman of the inquiry into the historical licensing and use of the anti-epileptic drug sodium valproate in Ireland, a role that involves leading investigations into the drug's impact on women of childbearing age and the potential risks to their children.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Ireland | 1 | 7.00 | 0.08% | +0% | 5,030,000 | 3,828 | $5,100 | 4$ |
| Totals | 1 | 5,030,000 | 3,828 | $5,100 | 4$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ireland:
In June 2024, barrister Bríd O’Flaherty was appointed as chairwoman of the inquiry.
7